Cornell researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it can wirelessly transmit brain activity data in a living animal for more than a year.
The first sprayable insecticide made of RNA can target and kill ravenous Colorado potato beetles while sparing most beneficial insects, making it a promising environmentally friendly option.
Cornell Tech researchers unveiled a robot that helps emergency room teams locate life-saving supplies faster, revealing how design can shape collaboration under pressure.
Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial.
The new Startup Cornell podcast episode features Van Hamilton Barbeau '11, MS/MBA '20, AVP at Ochsner Ventures, the venture capital arm of Ochsner Health.
Antonio Fernandez-Ruiz, assistant professor and Nancy and Peter Meinig Family Investigator in the Life Sciences in the Department of Neurobiology and Behavior in the College of Arts and Sciences, has been awarded a biomedical sciences grant from the Pew Charitable Trusts.
Fourteen members of Cornell’s faculty and staff are being recognized this year with Community-Engaged Practice and Innovation Awards from the David M. Einhorn Center for Community Engagement.
The American Society for Nutrition Foundation and the Novo Nordisk Foundation recognized Julia Finkelstein, associate professor in Nutritional Sciences, for her work on in vitamin B12 and one-carbon metabolism.
Imprint, an organization founded at Cornell Tech that is dedicated to decoding the body’s immune memory and uncovering the causes of chronic diseases, announced that it has raised over $15 million in funding.
A new study revealed how a deadly form of pancreatic cancer enters the bloodstream, solving a long-standing mystery of how the disease spreads and identifying a promising target for therapy.